Literature DB >> 30108965

What are the drugs of the future?

Huy X Ngo1, Sylvie Garneau-Tsodikova1.   

Abstract

Are small molecules or biologics the drugs of the future? Small-molecule drugs have historically been the pillars of traditional medicine. However, recently, we seem to be amidst a scientific revolution with the rise of many FDA-approved biologic drugs. This opinion article looks at the current state of small molecules and biologics and assesses what the future holds for these two broad classes of drugs.

Year:  2018        PMID： 30108965      PMCID： PMC6072476          DOI： 10.1039/c8md90019a

Source DB:  PubMed          Journal:  Medchemcomm        ISSN： 2040-2503            Impact factor:   3.597


  4 in total

1.  Defining the difference: What Makes Biologics Unique.

Authors:  Thomas Morrow; Linda Hull Felcone
Journal:  Biotechnol Healthc       Date:  2004-09

Review 2.  Small-molecule inhibitors of protein-protein interactions: progressing toward the reality.

Authors:  Michelle R Arkin; Yinyan Tang; James A Wells
Journal:  Chem Biol       Date:  2014-09-18

3.  New 2016 Data and Statistics for Global Pharmaceutical Products and Projections through 2017.

Authors:  Craig W Lindsley
Journal:  ACS Chem Neurosci       Date:  2017-08-16       Impact factor: 4.418

4.  Method to generate highly stable D-amino acid analogs of bioactive helical peptides using a mirror image of the entire PDB.

Authors:  Michael Garton; Satra Nim; Tracy A Stone; Kyle Ethan Wang; Charles M Deber; Philip M Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-29       Impact factor: 11.205
  4 in total
  12 in total

Review 1.  Nanotechnology-Assisted RNA Delivery: From Nucleic Acid Therapeutics to COVID-19 Vaccines.

Authors:  Chiara Rinoldi; Seyed Shahrooz Zargarian; Pawel Nakielski; Xiaoran Li; Anna Liguori; Francesca Petronella; Dario Presutti; Qiusheng Wang; Marco Costantini; Luciano De Sio; Chiara Gualandi; Bin Ding; Filippo Pierini
Journal:  Small Methods       Date:  2021-07-28

Review 2.  Regenerative Medicine Therapies for Prevention of Abdominal Adhesions: A Scoping Review.

Authors:  Samuel P Carmichael; Jaewook Shin; John W Vaughan; Prafulla K Chandra; John B Holcomb; Anthony J Atala
Journal:  J Surg Res       Date:  2022-03-17       Impact factor: 2.417

Review 3.  Strategies for Articular Cartilage Repair and Regeneration.

Authors:  Yanxi Liu; Karan M Shah; Jian Luo
Journal:  Front Bioeng Biotechnol       Date:  2021-12-17

4.  Discovery and Evaluation of Entry Inhibitors for SARS-CoV-2 and Its Emerging Variants.

Authors:  Arpan Acharya; Kabita Pandey; Michellie Thurman; Elizabeth Klug; Jay Trivedi; Kalicharan Sharma; Christian L Lorson; Kamal Singh; Siddappa N Byrareddy
Journal:  J Virol       Date:  2021-09-22       Impact factor: 5.103

5.  A novel plant lectin, NTL-125, interferes with SARS-CoV-2 interaction with hACE2.

Authors:  Anindya Sarkar; Sathi Paul; Charandeep Singh; Nilkanta Chowdhury; Papri Nag; Swarnava Das; Sahil Kumar; Anshul Sharma; Deepjyoti Kumar Das; Dipak Dutta; Krishan Gopal Thakur; Angshuman Bagchi; Surbhi Shriti; Kali P Das; Rajesh P Ringe; Sampa Das
Journal:  Virus Res       Date:  2022-04-07       Impact factor: 6.286

Review 6.  Activation of the Nrf2 Pathway as a Therapeutic Strategy for ALS Treatment.

Authors:  Liaisan Arslanbaeva; Marco Bisaglia
Journal:  Molecules       Date:  2022-02-22       Impact factor: 4.411

Review 7.  Use of Protamine in Nanopharmaceuticals-A Review.

Authors:  Ivana Ruseska; Katja Fresacher; Christina Petschacher; Andreas Zimmer
Journal:  Nanomaterials (Basel)       Date:  2021-06-07       Impact factor: 5.076

Review 8.  Pharmacological Potential of Small Molecules for Treating Corneal Neovascularization.

Authors:  Zachary Barry; Bomina Park; Timothy W Corson
Journal:  Molecules       Date:  2020-07-30       Impact factor: 4.411

9.  Simulation of Molecular Dynamics of SARS-CoV-2 S-Protein in the Presence of Multiple Arbidol Molecules: Interactions and Binding Mode Insights.

Authors:  Sophia S Borisevich; Edward M Khamitov; Maxim A Gureev; Olga I Yarovaya; Nadezhda B Rudometova; Anastasiya V Zybkina; Ekaterina D Mordvinova; Dmitriy N Shcherbakov; Rinat A Maksyutov; Nariman F Salakhutdinov
Journal:  Viruses       Date:  2022-01-10       Impact factor: 5.048

Review 10.  Potential therapeutic approaches for targeted inhibition of inflammatory cytokines following COVID-19 infection-induced cytokine storm.

Authors:  Nelli Morgulchik; Foteini Athanasopoulou; Edmund Chu; Yoriko Lam; Nazila Kamaly
Journal:  Interface Focus       Date:  2021-12-10       Impact factor: 3.906
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.